Smoking cessation and COPD
نویسندگان
چکیده
منابع مشابه
Smoking cessation and COPD.
The mainstay in smoking cessation is counselling in combination with varenicline, nicotine replacement therapy (NRT) or bupropion SR. Varenicline and combination of two NRTs is equally effective, while varenicline alone is more effective than either NRT or bupropion SR. NRT is extremely safe but cardiovascular and psychiatric adverse events with varenicline have been reported. These treatments ...
متن کاملPharmacoeconomics of COPD and smoking cessation.
nary manifestations of ankylosing spondylitis. Mayo Clin Proc 1977; 52:641–649 3 Lee-Chiong TL. Pulmonary manifestations of ankylosing spondylitis and relapsing polychondritis. Clin Chest Med 1998; 19:747–757 4 Tanoue LT. Pulmonary involvement in collagen vascular disease: a review of the pulmonary manifestations of the Marfan syndrome, ankylosing spondylitis, Sjögren’s syndrome and relapsing p...
متن کاملSmoking cessation strategies in patients with COPD.
Smoking cessation is the cornerstone of treatment of chronic obstructive pulmonary disease (COPD) patients. This systematic review evaluates the effectiveness of behavioural and pharmacological smoking cessation strategies in COPD patients. MEDLINE was searched from January 2002 to October 2011. Randomised controlled trials evaluating the effect of smoking cessation interventions for COPD patie...
متن کاملSuccessful Smoking Cessation in COPD: Association with Comorbidities and Mortality
Smoking cessation is the cornerstone of COPD management, but difficult to achieve in clinical practice. The effect of comorbidities on smoking cessation and risk factors for mortality were studied in a cohort of 739 COPD patients recruited in two Finnish University Hospitals. The diagnosis of COPD was done for the first time on average 5.5 years prior to the enrollment. Data from the medical re...
متن کاملCOPD disease progression and airway inflammation: uncoupled by smoking cessation.
C hronic obstructive pulmonary disease (COPD) is an important cause of morbidity, mortality and socioeconomic burden, and its prevalence continues to increase. It is expected to rise from its current position as the fourth to the third most common cause of death, worldwide, by the year 2020 [1]. Cigarette smoking is recognised as the cause of COPD in the vast majority of patients, although it r...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Respiratory Review
سال: 2013
ISSN: 0905-9180,1600-0617
DOI: 10.1183/09059180.00007212